Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
BLCO vs LNTH
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
BLCO vs LNTH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Drug Manufacturers - Specialty & Generic |
| Market Cap | $5.70B | $5.61B |
| Revenue (TTM) | $5.21B | $1.54B |
| Net Income (TTM) | $-219M | $234M |
| Gross Margin | 55.9% | 61.1% |
| Operating Margin | 5.9% | 20.2% |
| Forward P/E | 20.2x | 16.6x |
| Total Debt | $5.37B | $738K |
| Cash & Equiv. | $383M | $359M |
BLCO vs LNTH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 22 | May 26 | Return |
|---|---|---|---|
| Bausch + Lomb Corpo… (BLCO) | 100 | 94.1 | -5.9% |
| Lantheus Holdings, … (LNTH) | 100 | 125.7 | +25.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BLCO vs LNTH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BLCO is the clearest fit if your priority is growth exposure.
- Rev growth 6.5%, EPS growth -13.3%, 3Y rev CAGR 10.6%
- 6.5% revenue growth vs LNTH's 0.5%
- +46.8% vs LNTH's -17.8%
LNTH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.47
- 40.0% 10Y total return vs BLCO's -20.0%
- Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.5% revenue growth vs LNTH's 0.5% | |
| Value | Lower P/E (16.6x vs 20.2x) | |
| Quality / Margins | 15.2% margin vs BLCO's -4.2% | |
| Stability / Safety | Beta 0.47 vs BLCO's 1.39, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +46.8% vs LNTH's -17.8% | |
| Efficiency (ROA) | 10.8% ROA vs BLCO's -1.6%, ROIC 30.6% vs 1.2% |
BLCO vs LNTH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BLCO vs LNTH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LNTH leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BLCO is the larger business by revenue, generating $5.2B annually — 3.4x LNTH's $1.5B. LNTH is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to BLCO's -4.2%. On growth, BLCO holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $5.2B | $1.5B |
| EBITDAEarnings before interest/tax | $724M | $381M |
| Net IncomeAfter-tax profit | -$219M | $234M |
| Free Cash FlowCash after capex | $4M | $349M |
| Gross MarginGross profit ÷ Revenue | +55.9% | +61.1% |
| Operating MarginEBIT ÷ Revenue | +5.9% | +20.2% |
| Net MarginNet income ÷ Revenue | -4.2% | +15.2% |
| FCF MarginFCF ÷ Revenue | +0.1% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.4% | +4.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +66.7% | +5.8% |
Valuation Metrics
BLCO leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, LNTH's 13.8x EV/EBITDA is more attractive than BLCO's 17.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $5.7B | $5.6B |
| Enterprise ValueMkt cap + debt − cash | $10.7B | $5.3B |
| Trailing P/EPrice ÷ TTM EPS | -15.69x | 25.26x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.23x | 16.59x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 17.56x | 13.78x |
| Price / SalesMarket cap ÷ Revenue | 1.12x | 3.64x |
| Price / BookPrice ÷ Book value/share | 0.87x | 5.41x |
| Price / FCFMarket cap ÷ FCF | — | 15.84x |
Profitability & Efficiency
LNTH leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
LNTH delivers a 20.6% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-3 for BLCO. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BLCO's 0.82x. On the Piotroski fundamental quality scale (0–9), LNTH scores 5/9 vs BLCO's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -3.4% | +20.6% |
| ROA (TTM)Return on assets | -1.6% | +10.8% |
| ROICReturn on invested capital | +1.2% | +30.6% |
| ROCEReturn on capital employed | +1.6% | +17.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 |
| Debt / EquityFinancial leverage | 0.82x | 0.00x |
| Net DebtTotal debt minus cash | $5.0B | -$358M |
| Cash & Equiv.Liquid assets | $383M | $359M |
| Total DebtShort + long-term debt | $5.4B | $738,000 |
| Interest CoverageEBIT ÷ Interest expense | 0.71x | 16.89x |
Total Returns (Dividends Reinvested)
LNTH leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LNTH five years ago would be worth $39,000 today (with dividends reinvested), compared to $8,000 for BLCO. Over the past 12 months, BLCO leads with a +46.8% total return vs LNTH's -17.8%. The 3-year compound annual growth rate (CAGR) favors LNTH at -3.1% vs BLCO's -4.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -3.5% | +28.1% |
| 1-Year ReturnPast 12 months | +46.8% | -17.8% |
| 3-Year ReturnCumulative with dividends | -12.5% | -9.1% |
| 5-Year ReturnCumulative with dividends | -20.0% | +290.0% |
| 10-Year ReturnCumulative with dividends | -20.0% | +4002.4% |
| CAGR (3Y)Annualised 3-year return | -4.3% | -3.1% |
Risk & Volatility
Evenly matched — BLCO and LNTH each lead in 1 of 2 comparable metrics.
Risk & Volatility
LNTH is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than BLCO's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BLCO currently trades 84.6% from its 52-week high vs LNTH's 79.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.39x | 0.47x |
| 52-Week HighHighest price in past year | $18.92 | $108.91 |
| 52-Week LowLowest price in past year | $10.83 | $47.25 |
| % of 52W HighCurrent price vs 52-week peak | +84.6% | +79.1% |
| RSI (14)Momentum oscillator 0–100 | 46.9 | 60.5 |
| Avg Volume (50D)Average daily shares traded | 416K | 878K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates BLCO as "Hold" and LNTH as "Buy". Consensus price targets imply 18.8% upside for BLCO (target: $19) vs 17.2% for LNTH (target: $101).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $19.00 | $101.00 |
| # AnalystsCovering analysts | 16 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.3% |
LNTH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BLCO leads in 1 (Valuation Metrics). 1 tied.
BLCO vs LNTH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BLCO or LNTH a better buy right now?
For growth investors, Bausch + Lomb Corporation (BLCO) is the stronger pick with 6.
5% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. (LNTH) offers the better valuation at 25. 3x trailing P/E (16. 6x forward), making it the more compelling value choice. Analysts rate Lantheus Holdings, Inc. (LNTH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BLCO or LNTH?
On forward P/E, Lantheus Holdings, Inc.
is actually cheaper at 16. 6x.
03Which is the better long-term investment — BLCO or LNTH?
Over the past 5 years, Lantheus Holdings, Inc.
(LNTH) delivered a total return of +290. 0%, compared to -20. 0% for Bausch + Lomb Corporation (BLCO). Over 10 years, the gap is even starker: LNTH returned +40. 0% versus BLCO's -20. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BLCO or LNTH?
By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.
(LNTH) is the lower-risk stock at 0. 47β versus Bausch + Lomb Corporation's 1. 39β — meaning BLCO is approximately 197% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 82% for Bausch + Lomb Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — BLCO or LNTH?
By revenue growth (latest reported year), Bausch + Lomb Corporation (BLCO) is pulling ahead at 6.
5% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Bausch + Lomb Corporation grew EPS -13. 3% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BLCO or LNTH?
Lantheus Holdings, Inc.
(LNTH) is the more profitable company, earning 15. 2% net margin versus -7. 1% for Bausch + Lomb Corporation — meaning it keeps 15. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LNTH leads at 20. 2% versus 3. 7% for BLCO. At the gross margin level — before operating expenses — LNTH leads at 61. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BLCO or LNTH more undervalued right now?
On forward earnings alone, Lantheus Holdings, Inc.
(LNTH) trades at 16. 6x forward P/E versus 20. 2x for Bausch + Lomb Corporation — 3. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BLCO: 18. 8% to $19. 00.
08Which pays a better dividend — BLCO or LNTH?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is BLCO or LNTH better for a retirement portfolio?
For long-horizon retirement investors, Lantheus Holdings, Inc.
(LNTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 47)). Both have compounded well over 10 years (LNTH: +40. 0%, BLCO: -20. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BLCO and LNTH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.